Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
With the slowdown in world economic growth, the Clinical Laboratory Analyzers industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Clinical Laboratory Analyzers market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2018, Stratagem Market Insights analysts believe that in the next few years, Clinical Laboratory Analyzers market size will be further expanded, we expect that by 2023, The market size of the Clinical Laboratory Analyzers will reach XXX million $.
Clinical laboratory analyzers use measurement technologies including photometric and colorimetric testing, ion-selective potentiometry, and latex agglutination to analyze samples such as blood serum, plasma, and urine.
Approval and launch of new products is expected to propel growth of the global clinical laboratory analyzers market over the forecast period. For instance, in March 2020, Instrumentation Laboratory launched GEM Premier ChemSTAT in vitro diagnostic analyzer, a whole-blood analyzer designed for rapid basic metabolic panel testing at the point of care, with Intelligent Quality Management in the U.S.
Moreover, increasing funding to boost adoption of clinical laboratory analyzers is also expected to aid in growth of the market. For instance, in May 2020, Hurley Medical Center, U.S. received a US$ 50,000 of emergency relief funds from the Community Foundation of Greater Flint to purchase lab equipment, specifically for a laboratory analyzer machine.
Increasing prevalence of chronic disorders is expected to offer lucrative growth opportunities for players in the global clinical laboratory analyzers market. For instance, according to the study, “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition”, published in the journal Diabetes Research and Clinical Practice, in September 2019, 463 million people are expected to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.
The Covid-19 pandemic has led to decline in revenues of clinical laboratories, which is expected to hinder growth of the global clinical laboratory analyzers market. For instance, according to The Dark Intelligence Group Inc., clinical laboratories in the U.S. have witnessed decline in revenues by over US$ 5 billion since early March 2020.
Major players in the market are focused on patenting their products and technologies. For instance, in April 2020, LexaGene Holdings, Inc. filed a provisional patent application to the U.S. Patent and Trademark Office to protect the expanded testing capabilities of its LX Analyzer technology.
Key Takeaways:
- Approval and launch of new products to augment growth of the global clinical laboratory analyzers market over the forecast period
- Major players in the market are focused on adopting partnership strategies to enhance their market share. For instance, in May 2020, EKF Diagnostics signed a three-year distribution agreement with Tosoh Europe N.V. for the distribution of its Quo-Test HbA1c point-of-care (POC) analyzer in the Middle East and Africa.
- Major players operating in the global clinical laboratory analyzers market include, Siemens AG, Thermo Fisher Scientific Inc., EKF Diagnostics, Roche Diagnostics, Alere Inc., Sysmex Corporation, Nihon Kohden Corporation, LexaGene Holdings, Inc., Diagnostica Stago, Helena Laboratories, Instrumentation Laboratory, and International Technidyne Corporation
This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.
Section 1: Definition
Section (2 3): Manufacturer Detail
Siemens AG (Germany)
Thermo Fisher Scientific Inc. (U.S.)
Roche Diagnostics (Switzerland)
Alere Inc. (U.S.)
Sysmex Corporation (Japan)
Nihon Kohden Corporation (Japan)
Diagnostica Stago (France)
Helena Laboratories (U.S.)
Instrumentation Laboratory (U.S.)
International Technidyne Corporation (U.S.)
Section 4: Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7): Segmentation
Product Type Segmentation
- Automated
- Semi-automated
- Manual
Industry Segmentation
- Clinical Laboratories
- POC
Channel (Direct Sales, Distributor) Segmentation
Section 8: Trend (2019-2027)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion
